Riccardo Canevari
Chief Executive Officer at RADIOPHARM THERANOSTICS LIMITED
Net worth: 168 249 $ as of 2024-03-30
Profile
Riccardo Canevari is currently the Chief Executive Officer, MD & Director at Radiopharm Theranostics Ltd.
He previously worked as the Senior Vice President at Novartis Oncology, Inc. and as the Chief Commercial Officer at Advanced Accelerator Applications SA.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2022-09-26 | 4,605,789 ( 1.03% ) | 168 249 $ | 2024-03-30 |
Riccardo Canevari active positions
| Companies | Position | Start |
|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Chief Executive Officer | 2021-09-12 |
Former positions of Riccardo Canevari
| Companies | Position | End |
|---|---|---|
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Health Services |
| Private companies | 2 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
Advanced Accelerator Applications SA
 Advanced Accelerator Applications SA Medical SpecialtiesHealth Technology Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Rueil-Malmaison Cedex, France. | Health Technology |
- Stock Market
- Insiders
- Riccardo Canevari
